Business Daily from THE HINDU group of publications
Sunday, Jul 12, 2009
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Industry & Economy - Pharmaceuticals
Registration to be made mandatory for clinical research organisations

Thomas K. Thomas

New Delhi, July 11 To bring more transparency to clinical trials happening in India, the drug regulator has drafted guidelines for mandatory registration of clinical research organisations (CROs) in the country.

A clinical research organisation is an entity that undertakes trials of drugs on humans on behalf of a pharmaceutical company.

The drug regulator had earlier made it mandatory for companies to register all clinical trials taking place in the country. The move is aimed at keeping a tab on organisations undertaking clinical trials, even as multinational pharmaceutical companies are looking to make India the hub for clinical research given the easy accessibility to humans volunteering to take part in the drug trials at cheaper rates.

According to the proposed draft rules for registration of CROs, the drug regulator will give licences for five years to each company. Comments on the draft guidelines have been sought within 45 days after which they will be formalised. While the drug regulator has retained the powers to cancel licences issued to CROs, it has allowed the company to appeal within 90 days.

“These guidelines cover all organisations, individuals, institutions and companies that take the responsibility of the initiation or management or coordination of a clinical trial. It does not include clinical trial sites. An individual who both initiates and actually conducts, alone or with other associates, a clinical investigation and under whose immediate directions the test article is administered or dispensed or used involving a subject would be exempt,” the draft guidelines stated.

Keeping records

The guidelines make it mandatory for CROs to keep written records of trial-related duties and functions being carried out. They will also have to keep records of quality assurance and quality control according to the standard operative procedures designed for the purpose.

More Stories on : Pharmaceuticals | Regulatory Bodies & Rulings | Research & Development

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Recruiters see more hiring this year: Study


Rising fiscal deficit, a worrisome factor
MAT increase may hit Tier-II players
Budget lacks direction on policy issues
A good job by Finance Minister
Introduction of GST: A major challenge ahead for Govt
Pranab remains non-commital on rate cut
GSPL system pipes more volumes as Gujarat power cos switch to D6 gas
Registration to be made mandatory for clinical research organisations
Poor man’s jewellery taxed higher than the real
Doubled Customs duty on gold could open illegal trade channels
Training for public info officers
Weekly News Round up
Pawar sees potential to enhance ornamental fish exports
Travel agents push Indian airlines




The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line